Inspira activates U.S. consulting firm to execute transformation initiatives

Inspira Technologies (IINN) has activated a leading consulting firm to accelerate high-impact execution across strategic expansion, partner engagement, and advanced structuring pathways already in motion. The consulting firm is a specialized group that partners with biotech and medtech companies at critical inflection points. The firm’s expertise lies in structuring and leading the execution of high-value strategic transactions, accelerating commercial growth, and transforming enterprise value. The engagement follows a series of high-impact developments including major purchase orders, the formation of national-level strategic frameworks with government linked health authorities, and clinical integration of Inspira’s ART100 system in Tier-1 U.S. hospitals. Collectively, these achievements position Inspira to scale its commercial platform and deepen alignment across the broader medtech ecosystem. The consulting firm is currently facilitating targeted engagements with high-level stakeholders and evaluating scalable configurations to accelerate Inspira’s global footprint. The objective is to unlock execution pathways that can reshape the Company’s global market position and catalyze new layers of value creation in the second half of 2025.